Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Breathing Training to Study Lung Function in Children With Thalassemia

Tests breathing exercises on lung function and fitness in children with thalassemia major.

Plain-language title generated from the registry record
Registry title: Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia Major

Key facts

Where
Zagazig, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 10 years old?

Source: NCT07112703, who can take part

Where in Egypt

  • Zagazig University HospitalsZagazig, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Rawan Mohammed Khairy Mostafa Elsawy
Trial code
NCT07112703
Record updated
8 August 2025
Original description
The study was done to:Read full original descriptionShow less

Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia Major

The study was done to:

1. Investigate the effect of respiratory training on functional lung capacity and 2. To detect the effect of respiratory training on pulmonary functions in children with β-thalassemia major. 3. To detect the level of oxygen saturation and heart rate during and after blood transfusion in children with β-thalassemia major.

Inclusion: Diagnosed as thalassemia \& subjected to blood transfusion; Their age range from 6 to 10 years old; Both sexes, male and female, will participate; Subjects are able to follow simple verbal commands or instructions included in the procedures.

Exclusion: Children with cardiovascular, chest pulmonary, and heart diseases; Children with any postoperative cardiovascular, chest pulmonary, and heart conditions; Children with mental retardation or any other disability ; Children with visual or hearing defects.

ClinicalTrials.gov NCT07112703